Clinical trial · Interventional
Application of Cognitive Training Based on the Remind Strategy in Glioma Patients With Cognitive Impairment
Application of Cognitive Training Based on Remind Strategy in Glioma Patients With Cognitive Impairment
NCT06327048CI-TRIAL-00093496completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to form an interdisciplinary team to dynamically evaluate patient cognitive outcomes and develop an individualized cognitive training program for Chinese brain tumor patients
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Glioma | Glioma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Individual cognitive rehabilitation training based on Remind strategy was given | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Control group
- description
- Routine rehabilitation nursing
- type
- EXPERIMENTAL
- label
- Intervention group
- description
- On the basis of routine rehabilitation nursing, individual cognitive rehabilitation training based on Remind strategy was given
- interventionNames
- Other: Individual cognitive rehabilitation training based on Remind strategy was given
Primary outcomes (1)
- measure
- Montreal Cognitive Assessment(MoCA)
- timeFrame
- The day after admission, 7 days after surgery (baseline), at 4-week and 12-week of intervention.
- description
- The Montreal Cognitive Assessment (MoCA) is commonly used to assess cognitive function, typically taking about 15 minutes to complete. It has a total score of 30 points, with a score of ≥26 considered normal. Lower scores indicate more severe cognitive impairment. MoCA is advantageous due to its ease of administration, short duration, and high reliability and validity.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Conforming to the diagnostic criteria outlined in the "Chinese Clinical Guidelines for Diagnosis and Treatment of Central Nervous System Gliomas (2015)" ; 2. Patients diagnosed with brain gliomas through histopathological and/or cytological examination; 3. MoCA (Montreal Cognitive Assessment) score ≤ 26; 4. Karnofsky Performance Status (KPS) score ≥ 60, with no history of past illnesses; 5. Age ≥ 18 years; 6. Clear consciousness; 7. Willingness to participate and signed informed consent form. Exclusion Criteria: 1. Diagnosed with neurological or psychiatric disorders within the past two years; 2. Impaired consciousness; 3. Accompanied by severe complications such as infections; 4. Nursing Delirium Screening Checklist (Nu-DESC) score ≥ 2; 5. Patients with changes in condition or requiring repeat surgery; 6. Patients with multiple intracranial tumors; 7. Inability to effectively complete the questionnaire or withdrawal during the study.
References
Publications (1)
- DERIVEDMa Y, Zhou R, Ma Y, Mou C, He B, Sun D, Wu X, Dai Y, Ma P. Application of multidimensional cognitive training in the early postoperative period for glioma patients with cognitive impairment. J Neurooncol. 2026 Apr 27;177(3):128. doi: 10.1007/s11060-026-05575-7. PMID 42043588